SANTA CLARA, Calif., May 13, 2025 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading AI cloud platform service provider, today announced that MSCI has upgraded its Environmental, Social, and Governance (ESG) rating to 'AA' from 'A'. This upgrade recognizes Tuya's efforts to build a more sustainable and responsible business and places Tuya among the ESG leaders in its sector.MSCI, a leading provider of research-driven indices and analytics, reviewed companies in th ...

Invesco is an independent investment management firm dedicated to delivering an investment experience that helps people get more out of life.Be the first to know! Sign up for Invesco US Blog and get expert investment views as they post.Disclosure for all Invesco US articles: Before investing, carefully read the prospectus and/or summary prospectus and carefully consider the investment objectives, risks, charges and expenses. The information provided is for educational purposes only and does not constitute a ...

SANTA CLARA, Calif., May 13, 2025 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading AI cloud platform service provider, today announced that it will report its first quarter 2025 unaudited financial results after the market closes on Tuesday, May 20, 2025.Tuya's management will hold a conference call at 08:30 P.M. Eastern Time on Tuesday, May 20, 2025 (08:30 A.M. Hong Kong Time on Wednesday, May 21, 2025) to discuss the financial results. In advance of the confer ...

First product validated at the VALOR lab's new RF-shielded anechoic chamberCHANDLER, Ariz., May 13, 2025 /PRNewswire/ -- VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced that Metanoia Communications Inc.'s JURA Open Radio Unit (O-RU) has successfully completed end-to-end over-the-air (OTA) validation at the VIAVI Automated Lab-as-a-Service (VALOR™). It is the first product to be validated at the lab's new RF-shielded anechoic chamber to ensure compliance with O-RAN and 3GPP specifications. Me ...

Michael Fitzsimmons is a retired electronics engineer and avid investor. He advises investors to construct a well-diversified portfolio built on a core foundation of a high-quality low-cost S&P500 fund. For investors who can tolerate short-term risks, he advises an over-weight position in the technology sector, which he believes is still in the early stages of a long-term secular bull-market. For dividend income, and as a 4th generation oil & gas man, Fitzsimmons suggests investors consider a position in la ...

Group 1 - China has lifted its ban on airlines accepting Boeing planes following an agreement with the U.S. to temporarily reduce tariffs [1][5] - Chinese officials have started notifying domestic carriers that they can resume deliveries of U.S.-produced aircraft [1] - The U.S. and China have agreed to cut reciprocal tariffs by 115% for 90 days while continuing trade negotiations [5] Group 2 - Boeing faced delivery issues last month, with at least three jets returned to the U.S. due to Chinese customers rejecting new planes because of tariffs [2] - China accounts for approximately 10% of Boeing's commercial backlog, highlighting its significance as a growing aviation market [9] - Boeing planned to deliver 50 jets to Chinese carriers this year, including 41 that are either in production or pre-built [9] Group 3 - Chinese customers are expected to accept 25 out of 30 remaining 737 MAX jets built before 2023 that have not yet been delivered [11] - At least four 777 freighter planes are currently in production for Chinese carriers [12]

Core Viewpoint - Coinbase is set to join the S&P 500, leading to a significant increase in its stock price, which rose by 9.34% from $207.22 to $226.57 [1][8]. Group 1: Stock Performance - COIN shares experienced a rally of 9.34% following the announcement of its inclusion in the S&P 500 [1][8]. - The average 12-month price target for COIN is now $255.10, indicating a potential 12.59% increase from the current price [4][8]. - Analysts have noted that the average price targets are somewhat outdated given recent developments in the cryptocurrency market [9]. Group 2: Analyst Recommendations - Analysts on TipRanks have a moderate 'buy' rating for Coinbase, with 11 positive recommendations and 12 neutral ratings [3]. - Following recent developments, five analysts revised their price targets, with Rosenblatt Securities maintaining a target of $260 and Needham adjusting theirs from $330 to $270 [10]. - Compass Point changed its recommendation from 'sell' to 'neutral' while keeping a price target of $195, while Barclays and Goldman Sachs raised their targets to $202 and $209, respectively [11].

Core Insights - Infosys has announced a three-year strategic partnership with the Lawn Tennis Association (LTA) to serve as the official AI and Innovation Partner for the HSBC Championships at Queen's Club, London, until 2027 [1][2][3] - The partnership aims to leverage Infosys Topaz, an AI-first suite of technologies, to enhance player performance insights, fan engagement, and operational excellence [1][3] - This collaboration will also focus on sustainability efforts and community initiatives through digital platforms [1] Company Overview - Infosys is a global leader in next-generation digital services and consulting, with over 300,000 employees and operations in more than 56 countries [5] - The company has a strong track record in supporting major global tennis tournaments, including the Australian Open and Roland-Garros, and has established ties with the Association of Tennis Professionals (ATP) and the International Tennis Hall of Fame [2][5] - Infosys aims to transform tennis through AI and digital innovation, enhancing experiences for both players and fans [3][5] Industry Context - The HSBC Championships, a historic tournament in London, will host both WTA and ATP 500 events for the first time in over 50 years, marking a significant milestone in the tournament's evolution [2][3] - The LTA governs tennis in Great Britain, focusing on growing the sport from grassroots to professional levels, with a vision of "Tennis Opened Up" [4]

Core Insights - The report titled "The Cancer Paradox" reveals that oncologists are increasingly encountering advanced-stage cancers, attributing this trend primarily to screening barriers and other factors [3][4][5] - The report highlights the need for improved post-treatment monitoring tools, particularly the emerging ctDNA minimal residual disease (MRD) blood tests, which could enhance early detection of cancer recurrence [3][4][8] Group 1: Oncologists' Perspectives - 76% of oncologists report seeing more advanced-stage cancers, with 75% citing screening barriers as the main cause, followed by aging population (48%) and lifestyle factors (43%) [4][5] - 68% of oncologists believe missed or delayed follow-up care is a significant reason for missed cancer recurrence, while 50% point to imaging tests failing to detect recurrence early enough [5][13] - 94% of oncologists agree that ctDNA MRD testing could reduce delays in diagnosing cancer recurrence, although they face barriers to its widespread adoption [5][8] Group 2: Limitations of Current Monitoring Methods - Traditional methods for monitoring cancer recurrence, such as PET scans and MRIs, are viewed as expensive and invasive, with 50% of oncologists noting that imaging tests often fail to detect recurrence early [6][7] - Nearly all oncologists (96%) believe MRD testing can identify cancer recurrence earlier than current methods, with 89% emphasizing the importance of test sensitivity [7][8] Group 3: Adoption of ctDNA MRD Testing - 88% of oncologists support incorporating MRD testing into standard care for cancer-recurrence monitoring, but over half would be more inclined to recommend it with more clinical evidence, inclusion in clinical guidelines, and better insurance coverage [8][9] - A study published in NEJM found that the Haystack MRD test was a reliable alternative to tissue biopsies, identifying complete responses to immunotherapy faster than traditional imaging methods [9] Group 4: Oncologists' Challenges - 89% of oncologists believe early detection of cancer recurrence can improve outcomes, yet 79% report seeing patients whose recurrence was missed at earlier stages [13] - Anxiety and worry are cited as significant challenges for patients, with 87% of oncologists acknowledging this concern, compared to 53% who mention treatment side effects [13]

Core Insights - Happy Belly Food Group's Heal Wellness brand has signed its 50th franchise agreement in Grande Prairie, Alberta, marking a significant milestone in its expansion strategy [1][3][6] - The company aims to establish Heal Wellness as the leading acai bowl and smoothie brand in Canada, focusing on both organic and inorganic growth [3][4][5] Franchise Development - The signing of the 50th franchise agreement strengthens Heal Wellness's development pipeline and supports consistent organic growth [3][4] - Happy Belly has a total of 531 contractually committed retail franchise locations across its emerging brands, indicating robust expansion plans [6] Market Opportunity - Grande Prairie is identified as a strong market for a smoothie and acai bowl restaurant due to its youthful, health-conscious population and limited competition in the health-focused fast-casual space [7] - The city has a population nearing 70,000 and is experiencing steady economic growth, making it an ideal location for wellness-oriented food concepts [7] Business Model and Strategy - Heal Wellness employs a structured business model that mitigates typical entrepreneurial risks, equipping franchisees with necessary tools for success [5] - The company plans to further expand corporate store development while leveraging momentum from its franchise network, with multiple locations already under construction [5][6]